Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Putnam is a leading global strategy and management consulting firm focused exclusively on the life sciences sector. It provides scientific and strategic advisory services to pharmaceutical, biotechnology, diagnostics, and medical device companies worldwide. The firm specializes in product development strategy, commercialization planning, market access/pricing strategy, portfolio optimization/licensing support, medical affairs excellence and digital health. With over three decades of experience and more than 400 employees in ten offices globally—including Boston (HQ), New York City, San Francisco Bay Area/San Mateo CA., London UK., Paris FR., Tokyo JP.—Putnam has supported innovations across more than forty-five therapeutic areas for both large multinational biopharma companies as well as emerging biotech ventures. Since its rebranding in 2021 from “Putnam Associates” to “Putnam,” it has operated as part of Inizio Advisory while maintaining its specialized focus on life sciences.[1][2][3][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Putnam Den.